Europe: The United Kingdom has become the first country to authorise the updated version of the COVID-19 vaccine booster from Moderna that targets two coronavirus variants, including the Omicron strain and the original virus, from 2020.
According to the information, “The updated version of the COVID-19 vaccine booster which Moderna creates targets two COVID-19 variants known as a “bivalent” vaccine has been authorised for adult booster doses by the Medicines & Healthcare products Regulatory Agency (MHRA) after it was discovered to meet the United Kingdom regulator’s standards of safety, quality as well as effectiveness.”
The government of the United Kingdom stated that the plan to give approval for the dose was endorsed by the MHRA, the independent expert scientific advisory body of government, after carefully reviewing the evidence.
A clinical trial’s findings showing booster of Moderna targeting Omicron demonstrated a higher immune response to the variation led to its authorisation. According to the sources, the BA.4, as well as BA.5 subvariants, also demonstrated a “potent” reaction to the revised booster.
The release shared by the government of the United Kingdom highlighted, “No serious safety concerns were identified.”
MHRA Chief Executive Dr June Raine mentioned in the statement that as COVID-19 continues to mutate, the latest Moderna booster will help keep communities protected.
“The first generation of COVID-19 vaccines doses being used in the United Kingdom nations to give important protection against the disease as well as save lives. This bivalent vaccine gives a sharpened tool in our armoury to help protect everyone against this virus as the disease continues to develop.”